Key Takeaways
- • Chinese venture capital firms are targeting USD 35 billion across at least 60 new dollar-denominated funds, including approximately 40 VC funds, marking a sharp rebound after three years of record-low fundraising activity.
- • Major firms including Hongshan (formerly Sequoia China), IDG Capital, Matrix Partners China, and Future Capital are actively marketing new vehicles, with IDG planning a growth fund of approximately USD 2 billion and Future Capital raising a fund expected to exceed USD 200 million focused on AI hardware and drug discovery applications.
- • Investor appetite is being driven by Chinese artificial intelligence companies perceived as cost-competitive hedges against US market exposure, with breakthroughs from domestic developers Moonshot AI and DeepSeek, alongside progress in robotics and successful IPO listings, restoring market confidence.
- • A new generation of smaller specialist funds under USD 100 million is emerging, targeting niche sectors including robotics supply chains and AI agents; Nebulon Ventures, led by former Baidu Ventures executive Yongteng Wen, is raising USD 60 million as part of this wave.
- • The rebound follows a prolonged downturn driven by slowing domestic economic growth and US investment restrictions, with the market now re-engaging with Chinese technology startups after years of stagnation.
Summary
China's venture capital industry is experiencing a significant recovery after enduring three years of record-low fundraising activity. According to data from advisory firm Asante Capital cited by the Financial Times, VC managers are rushing to launch new investment vehicles, collectively targeting approximately USD 35 billion across at least 60 new dollar-denominated funds, with roughly 40 of these dedicated to venture capital. This represents a marked reversal from the prolonged downturn that characterized the sector through the prior three-year period.
The revival is primarily being fueled by renewed investor appetite for Chinese artificial intelligence and emerging technology sectors. Cost-competitive domestic AI developers such as Moonshot AI and DeepSeek have achieved significant technical breakthroughs that are attracting institutional capital. Investors view Chinese AI companies as a strategic hedge against concentrated US technology market exposure. Additional catalysts include progress in robotics development and a string of successful technology listings that have restored institutional confidence in the Chinese startup ecosystem.
Major established venture capital firms are leading the fundraising charge. Hongshan (HSG), the rebranded entity formerly known as Sequoia China, has informed limited partners of plans to launch an early-stage fund in 2026 alongside a renminbi-denominated vehicle. IDG Capital is planning a growth fund targeting approximately USD 2 billion plus a renminbi vehicle. Future Capital is raising a fund expected to exceed USD 200 million with a focus on AI hardware and scientific applications including drug discovery. Additional major managers including Matrix Partners China, ZhenFund, and Qiming are also actively marketing new funds or have recently closed vehicles.
Concurrently, a new generation of smaller specialist venture funds, typically under USD 100 million in size, is emerging to target specific technology niches. Nebulon Ventures, led by Yongteng Wen, a former alumnus of Baidu Ventures, is raising USD 60 million and positioning itself as part of this younger investor cohort. These smaller vehicles are increasingly focused on areas such as robotics supply chains and AI agents, reflecting the sector's renewed specialization around frontier technology categories.
The recovery marks a significant inflection point for institutional investors seeking China exposure after years of geopolitical headwinds and regulatory uncertainty that constrained the market. The combination of domestic technological progress, successful exits through IPO channels, and global investor repositioning toward AI-driven opportunities has created conditions for renewed capital deployment in the Chinese venture ecosystem.
The revival is primarily being fueled by renewed investor appetite for Chinese artificial intelligence and emerging technology sectors. Cost-competitive domestic AI developers such as Moonshot AI and DeepSeek have achieved significant technical breakthroughs that are attracting institutional capital. Investors view Chinese AI companies as a strategic hedge against concentrated US technology market exposure. Additional catalysts include progress in robotics development and a string of successful technology listings that have restored institutional confidence in the Chinese startup ecosystem.
Major established venture capital firms are leading the fundraising charge. Hongshan (HSG), the rebranded entity formerly known as Sequoia China, has informed limited partners of plans to launch an early-stage fund in 2026 alongside a renminbi-denominated vehicle. IDG Capital is planning a growth fund targeting approximately USD 2 billion plus a renminbi vehicle. Future Capital is raising a fund expected to exceed USD 200 million with a focus on AI hardware and scientific applications including drug discovery. Additional major managers including Matrix Partners China, ZhenFund, and Qiming are also actively marketing new funds or have recently closed vehicles.
Concurrently, a new generation of smaller specialist venture funds, typically under USD 100 million in size, is emerging to target specific technology niches. Nebulon Ventures, led by Yongteng Wen, a former alumnus of Baidu Ventures, is raising USD 60 million and positioning itself as part of this younger investor cohort. These smaller vehicles are increasingly focused on areas such as robotics supply chains and AI agents, reflecting the sector's renewed specialization around frontier technology categories.
The recovery marks a significant inflection point for institutional investors seeking China exposure after years of geopolitical headwinds and regulatory uncertainty that constrained the market. The combination of domestic technological progress, successful exits through IPO channels, and global investor repositioning toward AI-driven opportunities has created conditions for renewed capital deployment in the Chinese venture ecosystem.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.